Stocks
Eli Lilly and Company (LLY) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 6 605 | 7 641 | 8 739 | 9 434 | 12 456 | 17 934 | ||
| Changes by years, y/y, % | -32% | +16% | +14% | +8% | +32% | +5.2% | |||
Eli Lilly and Company. EBITDA US GAAP, bln rub
Eli Lilly and Company. EBITDA US GAAP, changes, %
Eli Lilly and Company. EBITDA US GAAP, sum by quarters, bln rub
Eli Lilly and Company (LLY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 2 320 | 6 401 | 3 604 | 3 211 | 4 719 | 17 934 | |
| Changes by years, y/y, % | +12% | +166% | +51% | +88% | +103% | |||
| Changes by quarters, q/q, % | +36% | +176% | -44% | -11% | +47% | |||
